Promote tumor angiogenesis by delivering pro-angiogenic factors (e.g., VEGF). Suppress anti-tumor immune responses by carrying immunosuppressive molecules (e.g., TGF-β, PD-L1). Facilitate tumor cell migration and metastasis via matrix metalloproteinases (MMPs). This evidence concerns the gene TGFB1 and neoplasm.